Strategic Interventions Drive Down Therapeutic Discontinuation Rate

Key Takeaways

• Personalized treatment strategies are crucial in managing lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved outcomes.
• Stereotactic radiosurgery and whole-brain radiotherapy remain important, but their roles are evolving with novel systemic therapies.
• Multidisciplinary approaches optimize treatment plans by considering genetic mutations, patient performance status, and potential side effects.
• Ongoing research aims to refine strategies for better survival and quality of life in patients with lung cancer brain metastases.